Company / Current Assets per Share
ENDRA Life Sciences Inc. Current Assets per Share History
FY2017-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$0.98
FY2020
5-year range
$0.88 / $8.13
FY2017-FY2020
Trend
+10.8%
vs FY2019
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share returned to growth in FY2020 after 2 years of decline, reaching $0.98.
Based on SEC 10-K filings.
0.98 in FY2020 with a 3-year CAGR of -50.7%.
Declined from $1.77 to $0.98 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -50.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2020, current assets per share increased 10.8% year-over-year.
Company context
Key Data Points
- Altman Z-Score -7.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2020 | $0.98 | +10.8% |
| FY2019 | $0.88 | -50.3% |
| FY2018 | $1.77 | -78.2% |
| FY2017 | $8.13 | - |
As of FY2020 · SEC 10-K · Updated Jun 28, 2026